[1] Chalasani N P,Hayashi P H,Bonkovsky H L,et al. ACG Clinical Guideline:the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol,2014,109（7）: 950-966.
[2] Hoofnagle J H,Serrano J,Knoben J E,et al. LiverTox:a website on drug-induced liver injury. Hepatology,2013,57（3）:873-874.
[3] Danan G,Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries. J Clin Epidemiol,1993,46（11）:1323-1330.
[4] Benichou C,Danan G,Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods:case reports with positive rechallenge. J Clin Epidemiol,1993,46（11）:1331-1336.
[5] Maria V A,Victorino R M. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology,1997,26（3）:664-669.
[6] Rockey D C,Seeff L B,Rochon J,et al. Causality assessment in drug-induced liver injury using a structured expert opinion process:comparison to the Roussel-Uclaf causality assessment method. Hepatology,2010,51（6）:2117-2126.
[7] Hayashi P H,Barnhart H X,Fontana R J,et al. Reliability of causality assessment for drug,herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network （DILIN）. Liver Int,2014,Mar 24. doi:10.1111/liv.12540. [Epub ahead of print]. |
